ROIV
#516
Roivant Sciences Ltd. - Common Shares
34.9 1 USD
+0.01%
Settore: Salute
Base: USD
Valuta di Profitto: USD
Intervallo Giornaliero
Intervallo Annuale
Variazione giornaliera
+1.16%
Variazione Mensile
+16.25%
Variazione di 6 mesi
+52.78%
Variazione Annuale
+90.66%
Chiusura Precedente
34.5 1
Open
34.9 1
Minimo
34.9 1
High
34.9 1
Volume
264
Financials
- Market Capitalization 25.11 B
- Employee 721
- Founded 2014
- CEO Matt Gline
- Website www.roivant.com
- Headquarter Bermuda
- FIGI N/A
- Industry Biotecnologia
Related tickers
| # | Nome | Prezzo | 24h % | 7d % | 1M % | 1Y % | Valore di Mercato | Ultimi 7 Giorni | |
|---|---|---|---|---|---|---|---|---|---|
| 387 |  ALNY Alnylam Pharmaceuticals, Inc. - Common Stock | 281.26 USD | -2.36% | -11.69% | -2.38% | -9.64% | 37.55 B USD | ||
| 493 |  MRNA Moderna, Inc. - Common Stock | 67.44 USD | +0.64% | -12.80% | +29.59% | +112.61% | 26.76 B USD | ||
| 520 |  RPRX Royalty Pharma plc - Class A Ordinary Shares | 55.67 USD | -1.38% | -3.75% | +2.56% | +49.41% | 24.75 B USD | ||
| 532 |  INSM Insmed Incorporated - Common Stock | 110.11 USD | +0.89% | -1.63% | +12.93% | -32.05% | 23.87 B USD |